Chris Davis Novartis Ag Transaction History

Davis Selected Advisers

$17.4 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $298,970 - $348,093	-3,713 Reduced 11.37%	28,943 $2.45 Million
Q1 2022 May 12, 2022	SELL	$80.11 - $90.62 $831,461 - $940,544	-10,379 Reduced 24.12%	32,656 $2.87 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $154,060 - $170,355	-1,933 Reduced 4.3%	43,035 $3.76 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $157,017 - $182,668	-1,920 Reduced 4.09%	44,968 $3.68 Million
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $210,031 - $231,985	2,464 Added 5.55%	46,888 $4.28 Million
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $264,528 - $311,952	3,168 Added 7.68%	44,424 $3.8 Million
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $187,992 - $227,387	2,408 Added 6.2%	41,256 $3.9 Million
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $70,640 - $78,260	860 Added 2.26%	38,848 $3.38 Million
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $821,277 - $924,482	10,148 Added 36.45%	37,988 $3.32 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $121,552 - $170,297	1,720 Added 6.58%	27,840 $2.3 Million
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $174,098 - $196,843	2,064 Added 8.58%	26,120 $2.47 Million
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $88,277 - $97,276	1,032 Added 4.48%	24,056 $2.09 Million
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $129,688 - $159,616	1,720 Added 8.07%	23,024 $2.1 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $440,471 - $503,805	5,848 Added 37.84%	21,304 $2.05 Million
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $10.5 Million - $11.7 Million	-142,117 Reduced 90.19%	15,456 $1.33 Million
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $886,151 - $1.03 Million	-13,238 Reduced 7.75%	157,573 $13.6 Million
Q2 2018 Aug 13, 2018	SELL	$64.91 - $73.36 $2.25 Million - $2.54 Million	-34,645 Reduced 16.86%	170,811 $12.9 Million
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $8.01 Million - $9.57 Million	-113,730 Reduced 35.63%	205,456 $16.6 Million
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $2.24 Million - $2.41 Million	-31,000 Reduced 8.85%	319,186 $26.8 Million
Q3 2017 Nov 16, 2017	BUY	$74.14 - $77.27 $26 Million - $27.1 Million	350,186	350,186 $30.1 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $216B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track Chris Davis's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis Selected Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Davis Selected Advisers and Chris Davis with notifications on news.

Account